SCHEMBL7841328

SCHEMBL7841328

Cc1ccccc1S(=O)(=O)O.N=C(N)n1nnc2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DGAT1 O75907 1/20 0.49
▸ GAA P10253 9/20 0.45
▸ MGAM O43451 8/20 0.45
▸ AMY1A P0DUB6 8/20 0.45
▸ SI P14410 8/20 0.45
▸ MGAM2 Q2M2H8 8/20 0.45
▸ FAAH O00519 1/20 0.43
▸ MGLL Q99685 1/20 0.43
▸ KMT2A Q03164 4/20 0.42
▸ HPGD P15428 2/20 0.42
▸ F2 P00734 2/20 0.42
▸ SLC9A1 P19634 1/20 0.42
▸ ALDH1A1 P00352 3/20 0.41
▸ HSD17B10 Q99714 3/20 0.41
▸ MAPT P10636 3/20 0.41
▸ TSHR P16473 2/20 0.41
▸ HTT P42858 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ F12 P00748 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2298377 0.82 SLC9A1 (0.53) DGAT1GAAMGAMAMY1ASI
SCHEMBL1520814 0.81 DGAT1 (0.72) DGAT1GAAMGAMAMY1ASI
Hydrochloric Acid SCHEMBL2681010 0.79 DGAT1 (0.70) DGAT1GAAMGAMAMY1ASI
Guanidine SCHEMBL811269 0.76 MYC (0.46) GAAKMT2AF2ALDH1A1TSHR
SCHEMBL7557183 0.72 KCNMA1 (0.65) GAAMGAMAMY1ASIMGAM2
SCHEMBL2583961 0.71 SLC9A1 (0.54) DGAT1GAAMGAMAMY1ASI
Hydroxyamine SCHEMBL8185329 0.71 MYC (0.50) GAAKMT2AALDH1A1TSHRKDM4E
Hydrazine SCHEMBL27884457 0.71 MYC (0.50) GAAKMT2AALDH1A1TSHRKDM4E
SCHEMBL29392580 0.71 MYC (0.53) GAAKMT2AALDH1A1TSHRKDM4E
SCHEMBL1748 0.71 MYC (0.53) GAAKMT2AALDH1A1TSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1131295-A1 QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 AND NK-2 RECEPTOR ANTAGONISTS Smithkline Beecham S.p.A. (IT) 2001-09-12 — — EP disclosed
WO-2000031037-A1 QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 AND NK-2 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM S.P.A. (IT) 2000-06-02 — — WO disclosed
Send feedback